Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum
- 1 November 2003
- journal article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 13 (6), 764-770
- https://doi.org/10.1111/j.1525-1438.2003.13319.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortalityCancer, 2010
- Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancerEuropean Journal of Surgical Oncology, 2000
- The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinomaCancer, 2000
- Title Pages / ContentsCytogenetic and Genome Research, 1999
- Cytoreductive Surgery in Ovarian Carcinoma Patients with a Documented Previously Complete Surgical ResponseGynecologic Oncology, 1995
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinomaCancer, 1994
- Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancerGynecologic Oncology, 1991
- Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapyCancer, 1990
- The Natural History and Treatment of Ovarian CancerAnnual Review of Medicine, 1981